MAPT and neurodegenerative disease: PET and CSF biomarkers are available for neurodegenerative diseases.4 CSF biomarkers include Aβ42 and Aβ40, total tau (T-tau), phosphorylated tau (P-tau), and neurofilament light chain (NFL).